clenbuterol has been researched along with dobutamine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (18.75) | 18.7374 |
1990's | 5 (31.25) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
O'Donnell, JM | 1 |
Dobson, A; Gleed, RD; Hackett, RP; Sanders, EA | 1 |
Akahane, K; Chiba, S; Furukawa, Y; Haniuda, M; Ogiwara, Y | 1 |
Bueno, L; Liberge, M | 1 |
Francès, H; Simon, P | 1 |
Bray, GA; Onai, T; Yamashita, J; York, DA | 1 |
Arioli, F; Badino, P; Belloli, C; Beretta, C; Carcano, R; Girardi, C; Odore, R; Re, G | 1 |
Arioli, F; Belloli, C; Beretta, C; Carcano, R | 1 |
Horinouchi, T; Koike, K | 1 |
Flower, L; Gray, R; Hotamisligil, G; Humphries, SE; Mohamed-Ali, V; Pinkney, J; Sethi, J; York, DA | 1 |
Bross, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BHJ; Schmidt, R | 1 |
Huang, Y; Mishler, K; O'Donnell, JM; Roerig, SC; Zhang, HT | 1 |
Ezaki, O; Goto, M; Kai, Y; Kawanaka, K; Minokoshi, Y; Miura, S; Shiuchi, T; Tamura, M | 1 |
Pattij, T; Schetters, D; Schoffelmeer, AN; van Gaalen, MM | 1 |
Ishikawa, M; Ito, A; Kawamura, N; Mototani, Y; Nakamura, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Shiozawa, K; Suita, K; Umeki, D; Yagisawa, Y | 1 |
16 other study(ies) available for clenbuterol and dobutamine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Antidepressive Agents; Benzimidazoles; Clenbuterol; Conditioning, Operant; Desipramine; Dobutamine; Down-Regulation; Ethanolamines; Male; Prenalterol; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1990 |
Action of sympathomimetic drugs on the bronchial circulation of the horse.
Topics: Animals; Blood Pressure; Bronchi; Bronchial Arteries; Clenbuterol; Dobutamine; Epinephrine; Horses; Norepinephrine; Phenylephrine; Receptors, Adrenergic; Regional Blood Flow; Sympathomimetics | 1991 |
Beta-adrenoceptor blocking effects of a selective beta 2-agonist, mabuterol, on the isolated, blood-perfused right atrium of the dog.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Chloride; Clenbuterol; Dobutamine; Dogs; Ethanolamines; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Procaterol; Propanolamines | 1989 |
Comparison of beta 1- and beta 2-adrenoceptor effects on gastric emptying of a fat meal in mice.
Topics: Acebutolol; Animals; Chromium Radioisotopes; Clenbuterol; Dietary Fats; Dobutamine; Gastric Emptying; Isoproterenol; Male; Mice; Propranolol; Receptors, Adrenergic, beta | 1989 |
Reserpine-induced hypothermia: participation of beta 1 and beta 2 adrenergic receptors.
Topics: Animals; Betaxolol; Body Temperature; Clenbuterol; Dobutamine; Ethanolamines; Male; Mice; Propanolamines; Receptors, Adrenergic, beta; Reserpine | 1987 |
Relationship between food intake and metabolic rate in rats treated with beta-adrenoceptor agonists.
Topics: Adrenergic beta-Agonists; Animals; Basal Metabolism; Clenbuterol; Dobutamine; Eating; Kinetics; Male; Oxygen Consumption; Phenoxyacetates; Phenoxypropanolamines; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1994 |
Differences between longitudinal and circular smooth muscle in beta-adrenergic control of motility of isolated equine ileum.
Topics: Adrenergic Agonists; Animals; Basement Membrane; Clenbuterol; Cyclic AMP; Dobutamine; Dose-Response Relationship, Drug; Female; Gastrointestinal Motility; Horses; Ileum; Isoproterenol; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Receptors, Adrenergic, beta | 1997 |
Suitability of the old fowl rectal caecum preparation for investigating the selectivity of beta-adrenergic drugs.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cecum; Chickens; Clenbuterol; Dobutamine; Dose-Response Relationship, Drug; Female; Fenoterol; Gastrointestinal Motility; In Vitro Techniques; Isoproterenol; Muscle Contraction; Procaterol; Tetrahydronaphthalenes | 1998 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Animals; Clenbuterol; Dioxoles; Dobutamine; Female; Humans; In Vitro Techniques; Interleukin-6; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Receptors, Adrenergic, beta | 2001 |
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Anti-Inflammatory Agents; CD3 Complex; Cell Nucleus; Clenbuterol; DNA; Dobutamine; Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; NF-kappa B; Receptors, Adrenergic, alpha; T-Lymphocytes; Tetradecanoylphorbol Acetate; Xamoterol | 2004 |
Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Animals; Antidepressive Agents; Appetitive Behavior; Cells, Cultured; Cerebral Cortex; Clenbuterol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Discrimination Learning; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Injections, Intraperitoneal; Male; Neurons; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Rolipram; Signal Transduction | 2005 |
An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Animals; Blotting, Northern; Clenbuterol; Dioxoles; Dobutamine; Gene Expression Regulation; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylephrine; Physical Conditioning, Animal; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Trans-Activators; Transcription Factors | 2007 |
On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists.
Topics: Adrenergic Agonists; Animals; Attention; Choice Behavior; Clenbuterol; Clonidine; Desipramine; Dobutamine; Dose-Response Relationship, Drug; Inhibition, Psychological; Isoproterenol; Male; Methylphenidate; Phenylephrine; Rats; Rats, Wistar; Reaction Time; Serial Learning | 2012 |
Role of β-adrenergic signaling in masseter muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Clenbuterol; Dobutamine; Male; MAP Kinase Signaling System; Masseter Muscle; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; TOR Serine-Threonine Kinases | 2019 |